Managing Crohn’s disease requires a combination of medication, dietary changes, lifestyle adjustments, and regular monitoring. Because the disease cycles between flares and remission, the goal isn’t a one-time fix but a long-term strategy that keeps inflammation low, prevents complications, and protects your quality of life. Here’s what that looks like in practice.
Medication: The Foundation of Treatment
Most people with Crohn’s need some form of medication to control the underlying inflammation, not just to feel better during a flare but to prevent damage that accumulates silently between flares. The specific drug depends on how severe your disease is, where in the gut it’s located, and how you’ve responded to previous treatments.
The most widely used class of biologic therapy targets a protein called TNF-alpha, which drives inflammation in the gut lining. These medications (infliximab, adalimumab, and certolizumab pegol are the common ones) neutralize that protein, reduce inflammation, and promote healing of the intestinal wall. They’ve been the backbone of Crohn’s treatment for over two decades. Another option works by blocking two immune-signaling molecules (IL-12 and IL-23) that activate the specific immune cells responsible for Crohn’s inflammation. A third class takes a gut-targeted approach: it blocks immune cells from migrating into the intestinal tissue in the first place, which means less systemic immune suppression and fewer body-wide side effects.
A newer category of oral medication has changed the landscape. Upadacitinib, a small-molecule drug taken as a daily pill, works by blocking an enzyme inside immune cells that relays inflammatory signals. In clinical trials involving over 1,000 patients, it outperformed placebo for both inducing and maintaining remission. Notably, some patients experienced symptom relief within five to six days of starting treatment, and remission was sustained for up to 30 months in long-term studies. The induction dose is typically higher, then stepped down to a lower maintenance dose.
Dietary Strategies That Reduce Flares
Diet alone doesn’t replace medication, but it plays a meaningful role in managing inflammation and extending remission. The Crohn’s Disease Exclusion Diet (CDED) is the most studied structured approach and works in three phases. The first phase (weeks one through six) is the most restrictive, eliminating foods thought to trigger intestinal inflammation while emphasizing high-quality protein sources and foods that support a healthy gut microbiome. Phase two (weeks six through twelve) gradually reintroduces previously restricted foods. The third phase, starting at week thirteen and lasting at least nine months, serves as a more flexible maintenance plan that can be personalized over time.
The diet recommends specific foods not because they’re therapeutic on their own but because they ensure nutritional completeness and feed beneficial gut bacteria. Chicken breast and eggs provide protein. Potatoes, bananas, and apples supply resistant starch and pectin, both of which help produce short-chain fatty acids that nourish the intestinal lining. If you can’t tolerate any of these, a dietitian experienced in IBD can suggest alternatives. The key principle across any Crohn’s-friendly eating plan is reducing processed foods, emulsifiers, and additives that appear to disrupt the gut barrier.
Nutritional Deficiencies to Watch For
Crohn’s disease, especially when it affects the small intestine, makes it harder to absorb nutrients. This isn’t a minor footnote. It’s one of the most common ways the disease quietly undermines your health even when symptoms feel controlled.
About 19% of people with Crohn’s are deficient in vitamin B12, with higher rates among those who have ileal involvement or have had bowel resections. Iron deficiency and low transferrin saturation (the protein that carries iron in your blood) affect roughly 22% to 29% of patients, and anemia shows up in about the same proportion, rising to 25% during active disease. Folic acid deficiency is significantly more common in Crohn’s patients than in healthy individuals (around 11% versus essentially 0%). Magnesium deficiency runs at about 18%. Vitamin D deficiency affects over a third of patients, with the risk climbing the longer you’ve had the disease: those with vitamin D deficiency had a median disease duration of nearly 14 years compared to about 7.5 years for those with sufficient levels.
Regular blood work to check these levels, especially B12, iron, vitamin D, and folate, allows you to supplement before deficiencies cause problems like fatigue, bone thinning, or nerve damage.
Exercise During Remission and Flares
Physical activity is one of the most underused tools in Crohn’s management. The research consistently supports moderate-intensity exercise, done three to five times per week for at least 30 minutes, as safe and beneficial. Both aerobic exercise and resistance training are recommended. In studies of IBD patients who followed structured exercise programs, participants saw a significant reduction in total body fat and an increase in lean tissue mass, making exercise a practical way to counteract the muscle wasting and metabolic changes that chronic inflammation causes.
Low-intensity activity is a reasonable starting point during recovery from a flare or after surgery, and pilot studies suggest that high-intensity training is feasible for some patients in stable remission. The main guideline is to match intensity to your current disease activity and tolerance, then build gradually.
Stress Management and Mental Health
Stress doesn’t cause Crohn’s, but it reliably makes it worse. The connection runs both ways: living with a chronic, unpredictable illness increases anxiety and depression, and psychological distress can trigger flares through its effects on the immune system and gut function.
A randomized controlled trial found that patients who received a combined program of cognitive behavioral therapy and mindfulness-based stress reduction had significantly reduced disease activity at three months, measured not just by symptom scores but by objective inflammatory markers in their blood and stool. This makes psychological support more than a comfort measure. It’s a tool that measurably lowers inflammation. If formal therapy isn’t accessible, even a consistent mindfulness or relaxation practice can help stabilize the stress-inflammation cycle.
Monitoring: How to Know What’s Happening Inside
Symptoms alone are an unreliable guide to how active your Crohn’s is. You can feel relatively fine while inflammation quietly damages your intestinal wall. That’s why objective monitoring matters.
Fecal calprotectin, a stool test, is the most practical non-invasive way to track gut inflammation between colonoscopies. A reading below 50 micrograms per gram essentially rules out significant inflammation, with a negative predictive value above 95%. International guidelines use a threshold below 150 micrograms per gram as the target associated with remission. Readings above 250 micrograms per gram are associated with large ulcers and typically call for closer monitoring or a colonoscopy to confirm a flare. The gray zone between 50 and 250 is harder to interpret and usually means more frequent testing to watch the trend.
Tracking your calprotectin levels over time, rather than reacting to a single number, gives you and your doctor a much clearer picture of whether your treatment is working or needs adjustment.
When Surgery Becomes Part of the Plan
Surgery isn’t a failure of management. It’s a tool that becomes necessary when medication can’t control a stricture, fistula, or segment of severely damaged bowel. The most common procedure is resection, removing the affected portion and reconnecting the healthy ends. Among patients who undergo their first resection, about 12.6% need a second surgery within one year, 22.4% within five years, and 32.2% within ten years. The majority of repeat surgeries (57%) are due to disease recurring at or near the surgical site, while 40% are for planned stoma reversals.
These numbers underscore why surgery is almost always paired with medication afterward. Starting or restarting biologic therapy after resection significantly lowers the chance of recurrence.
Vaccines and Immune Safety
If you take immunosuppressive medications for Crohn’s, including biologics, immunomodulators like azathioprine or methotrexate, or certain oral therapies like upadacitinib, live vaccines are generally not safe for you. Live vaccines contain a weakened form of the virus or bacteria, which a suppressed immune system may not be able to handle safely.
The live vaccines to be aware of include the nasal spray flu vaccine (the injectable version is fine), MMR (measles, mumps, rubella), varicella (chickenpox), the older live shingles vaccine (a non-live version called Shingrix is available and preferred), oral typhoid, and yellow fever. Ideally, your vaccination status should be reviewed and updated before starting immunosuppressive therapy. If you’re already on treatment, inactivated vaccines like the flu shot, pneumococcal vaccine, and COVID vaccines remain safe and are strongly recommended.
Smoking and Disease Course
Smoking is the single most modifiable risk factor that worsens Crohn’s disease. Active smokers experience more frequent flares, respond less well to medication, and face higher rates of surgery and post-surgical recurrence compared to nonsmokers. Quitting smoking improves treatment response and reduces the likelihood of needing repeat operations. If you smoke and have Crohn’s, cessation is the highest-impact lifestyle change you can make.